HeraMED inks partner agreement with Telstra Health

HeraMED (ASX:HMD) shares are surging today following the announcement of a partnership agreement with Telstra Health.

HeraMED (ASX:HMD) lands contract with leading private WA obstetrics and gynaecology group

HeraMED (HMD) had penned a new contract with Joondalup Obstetrics and Gynaecology Group (JOGG) to deploy…

Gold Coast Hospital welcomes trial of the HeraMED’s (ASX:HMD) HeraCARE platform

Pregnancy technology company HeraMED (ASX:HMD) has inked a memorandum of understanding (MOU) with Gold Coast Hospital…
HeraMED (ASX:HMD) - President, North America, Keith Koby

HeraMED (ASX:HMD) appoints Keith Koby as President, North America

HeraMED (ASX:HMD) has appointed former Nanosonics (NAN) Senior Vice President, North America Keith Koby as its…
The Market Online Video

HeraMED (ASX:HMD) completes $4m private placement

HeraMED (ASX:HMD) has completed a $4 million private placement to fund early commercialisation initiatives.

HeraMED (ASX:HMD) halts trade ahead of capital raise

Pregnancy technology company HeraMED (ASX:HMD) has entered a trading halt as the company prepares to undertake…

HeraMED (ASX:HMD) partners with e-Lōvu Health to supply pregnancy care tech in the US

Pregnancy care tech specialist HeraMED (ASX:HMD) has partnered with e-Lōvu Health to supply its HeraCARE remote…
HeraMED (ASX:HMD) - CEO & Co Founder, David Groberman

HeraMED (ASX:HMD) completes HeraBEAT trial with “excellent” results

Pregnancy technology company HeraMED (ASX:HMD) has completed the HeraBEAT clinical trial with Israel's Sheba Medical Center…

HeraMED (ASX:HMD) signs “significant milestone” with a Perth hospital

Digital maternity care company HeraMED (ASX:HMD) has hit a "truly significant milestone" with a Perth hospital,…
Heramed (ASX:HMD) - CEO and Co Founder, David Groberman

HeraMED (ASX:HMD) raises $2.39m via convertible note placement

HeraMED (ASX:HMD) has raised roughly $2.39 million through a convertible note placement.
Heramed (ASX:HMD) - CEO and Co Founder, David Groberman

HeraMED (ASX:HMD) halts trade, eyes capital raise

Pregnancy technology company HeraMED (ASX:HMD) has entered a trading halt while it considers, plans and executes…
HeraMED (ASX:HMD) - CEO, David Groberman

HeraMED (ASX:HMD) receives positive interim results in HeraCARE paid pilot program

Pregnancy technology company HeraMED (ASX:HMD) has received interim results from its paid pilot agreement with Obstetrix…

HeraMED’s (ASX:HMD) technology shortlisted for government tender in Spain

HeraMED's (ASX:HMD) technology solution, HeraCare, has been shortlisted for a Government tender in Spain.
HeraMED (ASX:HMD) - CEO, David Groberman

HeraMED’s (ASX:HMD) paid pilot of HeraCARE begins

Medical data and tech developer HeraMED (ASX:HMD) has begun a paid pilot of its HeraCARE solution,…
HeraMED (ASX:HMD) - CEO & Co Founder, David Groberman

HeraMED (ASX:HMD) signs pilot agreement with Obstetrix

Pregnancy technology company HeraMED (ASX:HMD) has signed a pilot agreement with Obstetrix Medical Group.
HeraMED (ASX:HMD) - CEO, David Groberman

HeraMED (ASX:HMD) arranges tech pilot at Joondalup Health Campus

Pregnancy technology company HeraMED (ASX:HMD) has signed a commercial agreement with Joondalup Health Campus (JHC).
The Market Online Video

Israel’s largest hospital to pilot HeraMED (ASX:HMD) pregnancy tech

HeraMED (ASX:HMD) will have its pregnancy monitoring solutions, HeraBEAT and HeraCARE, tested in a pilot study…
HeraMED (ASX:HMD) - CEO & Co Founder, David Groberman

HeraMED (ASX:HMD) raises $2.3M

HeraMED (ASX:HMD) has successfully raised over $2.3 million to progress its commercialisation strategy.

HeraMED (ASX:HMD) plans capital raise

HeraMed (ASX:HMD) has entered a trading halt as it plans an upcoming capital raise.